Hyperandrogénie : la Cour européenne des droits de l’homme juge le procès de Caster Semenya pas équitable mais ne se prononce pas sur le fond,France Info


The European Court of Human Rights (ECHR) has issued a significant ruling concerning the case of South African Olympic champion Caster Semenya, addressing the fairness of the legal proceedings she faced regarding her eligibility to compete in women’s athletics. While the court found that Semenya’s case was not handled equitably, it deliberately chose not to rule on the substantive issue of whether the rules themselves, which require athletes with differences in sex development (DSD) to lower their testosterone levels to compete in certain events, are discriminatory.

The ECHR’s decision, reported by France Info, centers on procedural grounds. The court determined that Switzerland, the country against which Semenya had brought her case, failed to provide her with an effective remedy to challenge the regulations imposed by World Athletics (formerly the IAAF). Specifically, the ECHR found that the Swiss Federal Tribunal, which had previously upheld World Athletics’ rules, had not adequately considered Semenya’s arguments and had not afforded her a fair hearing. This procedural failing is what led to the court’s judgment that the process was not equitable.

It is crucial to understand that the ECHR’s ruling does not invalidate the World Athletics rules that Semenya has challenged. The court explicitly stated that it was not examining the merits or the underlying fairness of the regulations themselves. This means that the debate over whether these rules are discriminatory or justifiable in the context of fair competition remains open.

Caster Semenya, a two-time Olympic gold medalist in the 800 meters, has DSD, a condition that results in naturally high levels of testosterone. World Athletics introduced rules in 2018 that require female athletes with elevated testosterone levels to medically lower them to be eligible to compete in events ranging from 400 meters to one mile. Semenya, who has refused to undergo such treatment, has been unable to compete in her preferred events.

Her legal challenge in Switzerland was an attempt to overturn these regulations, arguing they were discriminatory and violated her human rights. While the Swiss courts ultimately sided with World Athletics, the ECHR’s finding of inequitable proceedings highlights concerns about the judicial process afforded to Semenya in her attempts to appeal.

This ruling is a complex one, with implications for both athlete rights and the governance of international sport. It underscores the importance of fair and effective legal recourse for individuals facing decisions by sporting bodies. However, it also leaves the core debate about testosterone regulations in women’s athletics unresolved, a discussion that continues to be a subject of intense scrutiny and debate within the global sporting community. The ECHR’s focus was on the process, not the policy, and athletes like Caster Semenya continue to navigate a challenging landscape in their pursuit of fair competition.


Hyperandrogénie : la Cour européenne des droits de l’homme juge le procès de Caster Semenya pas équitable mais ne se prononce pas sur le fond


AI has delivered the news.

The answer to the following question is obtained from Google Gemini.


France Info published ‘Hyperandrogénie : la Cour européenne des droits de l’homme juge le procès de Caster Semenya pas équitable mais ne se prononce pas sur le fond’ at 2025-07-10 10:28. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.

Leave a Comment